• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unleashing the TLR9-driven multilineage differentiation of myeloid leukemia cells .

作者信息

Piwocka Katarzyna

机构信息

Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

出版信息

Mol Ther Nucleic Acids. 2025 Jan 2;36(1):102430. doi: 10.1016/j.omtn.2024.102430. eCollection 2025 Mar 11.

DOI:10.1016/j.omtn.2024.102430
PMID:39850320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11754007/
Abstract
摘要

相似文献

1
Unleashing the TLR9-driven multilineage differentiation of myeloid leukemia cells .释放TLR9驱动的髓系白血病细胞多谱系分化
Mol Ther Nucleic Acids. 2025 Jan 2;36(1):102430. doi: 10.1016/j.omtn.2024.102430. eCollection 2025 Mar 11.
2
Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice.双功能CpG-STAT3诱饵寡核苷酸触发小鼠急性髓系白血病多谱系分化。
Mol Ther Nucleic Acids. 2024 Jul 16;35(3):102268. doi: 10.1016/j.omtn.2024.102268. eCollection 2024 Sep 10.
3
Acute myeloid leukemia with multilineage dysplasia in children.儿童多系发育异常的急性髓系白血病
Int J Hematol. 2007 Nov;86(4):358-63. doi: 10.1532/IJH97.07025.
4
Interferon-alpha enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells.α干扰素增强化疗药物对人髓性白血病细胞的细胞毒性和细胞生长抑制活性。
J Interferon Cytokine Res. 1996 Feb;16(2):139-46. doi: 10.1089/jir.1996.16.139.
5
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.靶向白血病细胞的 STAT3 沉默和 TLR9 触发产生全身性抗肿瘤免疫。
Blood. 2014 Jan 2;123(1):15-25. doi: 10.1182/blood-2013-07-517987. Epub 2013 Oct 29.
6
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.TLR9 介导的 siRNA 递送至体内靶向正常和恶性人类造血细胞。
Blood. 2013 Feb 21;121(8):1304-15. doi: 10.1182/blood-2012-07-442590. Epub 2013 Jan 3.
7
Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.人类髓系白血病在SCID-hu小鼠的人骨髓环境中的生长。
Blood. 1993 Oct 15;82(8):2526-36.
8
Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia.Toll样受体9（TLR9）和髓样分化因子88（MYD88）基因多态性与慢性淋巴细胞白血病风险之间无关联。
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3245-3250. doi: 10.22034/APJCP.2017.18.12.3245.
9
[Simultaneous occurrence of acute myeloid leukemia with multilineage dysplasia and multiple myeloma].急性髓系白血病伴多系发育异常与多发性骨髓瘤同时发生
Rinsho Ketsueki. 2003 Jan;44(1):19-24.
10
The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study.Toll样受体9激动剂（GNKG168）在微小残留病阳性的儿童急性白血病患者体内诱导出独特的免疫激活模式：TACL T2009 - 008 I期研究结果
Pediatr Hematol Oncol. 2019 Nov;36(8):468-481. doi: 10.1080/08880018.2019.1667461. Epub 2019 Sep 18.

本文引用的文献

1
Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice.双功能CpG-STAT3诱饵寡核苷酸触发小鼠急性髓系白血病多谱系分化。
Mol Ther Nucleic Acids. 2024 Jul 16;35(3):102268. doi: 10.1016/j.omtn.2024.102268. eCollection 2024 Sep 10.
2
Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity.Toll 样受体 9 激动剂和联合疗法：调节肿瘤免疫微环境以实现全身抗肿瘤免疫的策略。
Br J Cancer. 2022 Nov;127(9):1584-1594. doi: 10.1038/s41416-022-01876-6. Epub 2022 Jul 28.
3
Differentiation therapy for myeloid malignancies: beyond cytotoxicity.髓系恶性肿瘤的分化治疗：超越细胞毒性。
Blood Cancer J. 2021 Dec 4;11(12):193. doi: 10.1038/s41408-021-00584-3.
4
Catch me if you can: how AML and its niche escape immunotherapy.《逃无可逃：AML 及其生态位如何逃避免疫疗法》
Leukemia. 2022 Jan;36(1):13-22. doi: 10.1038/s41375-021-01350-x. Epub 2021 Jul 23.
5
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.TLR9 在慢性淋巴细胞白血病中的表达鉴定出一个促迁移亚群和新的治疗靶点。
Blood. 2021 Jun 3;137(22):3064-3078. doi: 10.1182/blood.2020005964.
6
Immune escape and immunotherapy of acute myeloid leukemia.急性髓系白血病的免疫逃逸与免疫治疗。
J Clin Invest. 2020 Apr 1;130(4):1552-1564. doi: 10.1172/JCI129204.
7
Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo.髓系细胞靶向 miR-146a 模拟物抑制体内 NF-κB 驱动的炎症和白血病进展。
Blood. 2020 Jan 16;135(3):167-180. doi: 10.1182/blood.2019002045.
8
Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.miRNA拮抗剂在体外和体内对髓系细胞的靶向递送
Methods Mol Biol. 2019;1974:141-150. doi: 10.1007/978-1-4939-9220-1_10.
9
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.STAT3 和 STAT5 信号对造血系统癌症中基因调控和染色质重塑的影响。
Leukemia. 2018 Aug;32(8):1713-1726. doi: 10.1038/s41375-018-0117-x. Epub 2018 Mar 27.
10
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.骨髓龛中小分子 RNA-126 的转移调控慢性髓系白血病中白血病干细胞的自我更新。
Nat Med. 2018 May;24(4):450-462. doi: 10.1038/nm.4499. Epub 2018 Mar 5.